LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $22,339,000 | -12.8% | 224,422 | 0.0% | 0.16% | -11.4% |
Q2 2019 | $25,617,000 | -9.2% | 224,422 | 0.0% | 0.18% | -12.0% |
Q1 2019 | $28,212,000 | -7.4% | 224,422 | 0.0% | 0.20% | -22.5% |
Q4 2018 | $30,454,000 | -50.6% | 224,422 | 0.0% | 0.26% | -41.6% |
Q3 2018 | $61,601,000 | +32.5% | 224,422 | 0.0% | 0.44% | +20.8% |
Q2 2018 | $46,493,000 | +29.4% | 224,422 | 0.0% | 0.37% | +31.2% |
Q1 2018 | $35,943,000 | +17.0% | 224,422 | 0.0% | 0.28% | -14.7% |
Q4 2017 | $30,730,000 | – | 224,422 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $6,891 | 2.63% |
VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |